101 related articles for article (PubMed ID: 28265335)
1. Inappropriate Off-label Use of a Qualitative, Point-of-care hCG Device.
Nerenz RD; Gronowski AM; Grenache DG
West J Emerg Med; 2017 Feb; 18(2):324-325. PubMed ID: 28265335
[No Abstract] [Full Text] [Related]
2. In reply to: “Inappropriate Off-label Use of a Qualitative, Point-of-care hCG Device”.
Gottlieb M; Wnek K; Moskoff J; Christian E; Bailitz J
West J Emerg Med; 2017 Feb; 18(2):326. PubMed ID: 29911828
[No Abstract] [Full Text] [Related]
3. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
Milhorn D; Korpi-Steiner N
Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
[TBL] [Abstract][Full Text] [Related]
4. Performance of qualitative urinary hCG assays.
Nickmans S; Vermeersch P; Van Eldere J; Billen J
Acta Clin Belg; 2014 Aug; 69(4):277-9. PubMed ID: 24846178
[TBL] [Abstract][Full Text] [Related]
5. Heterophile antibody interference in qualitative urine/serum hCG devices: Case report.
Patel KK; Gronowski AM
Clin Biochem; 2016 Jun; 49(9):729-731. PubMed ID: 26968106
[TBL] [Abstract][Full Text] [Related]
6. Gelofusine affects the quality control performance of QuickVue point-of-care human chorionic gonadotropin test devices.
de Boer D; Houben C; Bekers O; Menheere PP
Clin Biochem; 2010 Nov; 43(16-17):1371-2. PubMed ID: 20727868
[TBL] [Abstract][Full Text] [Related]
7. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
[TBL] [Abstract][Full Text] [Related]
8. Analytical sensitivity of four commonly used hCG point of care devices.
Kamer SM; Foley KF; Schmidt RL; Greene DN
Clin Biochem; 2015 Apr; 48(6):448-52. PubMed ID: 25549977
[TBL] [Abstract][Full Text] [Related]
9. The hCG assay or pregnancy test.
Cole LA
Clin Chem Lab Med; 2012 Apr; 50(4):617-30. PubMed ID: 22149742
[TBL] [Abstract][Full Text] [Related]
10. Assessment of biotin interference with qualitative point-of-care hCG test devices.
Williams GR; Cervinski MA; Nerenz RD
Clin Biochem; 2018 Mar; 53():168-170. PubMed ID: 29395091
[TBL] [Abstract][Full Text] [Related]
11. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
[TBL] [Abstract][Full Text] [Related]
12. Substituting whole blood for urine in a bedside pregnancy test.
Fromm C; Likourezos A; Haines L; Khan AN; Williams J; Berezow J
J Emerg Med; 2012 Sep; 43(3):478-82. PubMed ID: 21875776
[TBL] [Abstract][Full Text] [Related]
13. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG.
Johnson S; Eapen S; Smith P; Warren G; Zinaman M
J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf.
Nerenz RD; Butch AW; Ashby L; Woldemariam GA; Gronowski AM
Clin Biochem; 2015 Aug; 48(12):815-7. PubMed ID: 25916816
[TBL] [Abstract][Full Text] [Related]
15. Estimating the hCGβcf in urine during pregnancy.
Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin (hCG) testing--part II.
Diwan CA
MLO Med Lab Obs; 2011 Mar; 43(3):26, 28. PubMed ID: 21446579
[No Abstract] [Full Text] [Related]
17. A Point-of-Care Immunosensor for Human Chorionic Gonadotropin in Clinical Urine Samples Using a Cuneated Polysilicon Nanogap Lab-on-Chip.
Balakrishnan SR; Hashim U; Gopinath SC; Poopalan P; Ramayya HR; Iqbal Omar M; Haarindraprasad R; Veeradasan P
PLoS One; 2015; 10(9):e0137891. PubMed ID: 26368287
[TBL] [Abstract][Full Text] [Related]
18. A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements.
Albersen A; Kemper-Proper E; Thelen MH; Kianmanesh Rad NA; Hoedemaeker RF; Boesten LS
Clin Chem Lab Med; 2011 Jun; 49(6):1029-32. PubMed ID: 21410410
[TBL] [Abstract][Full Text] [Related]
19. A device architecture for three-dimensional, patterned paper immunoassays.
Schonhorn JE; Fernandes SC; Rajaratnam A; Deraney RN; Rolland JP; Mace CR
Lab Chip; 2014 Dec; 14(24):4653-8. PubMed ID: 25300302
[TBL] [Abstract][Full Text] [Related]
20. Background hCG in non-pregnant individuals: need for more sensitive point-of-care and over-the-counter pregnancy tests.
Cole LA; Ladner DG
Clin Biochem; 2009 Feb; 42(3):168-75. PubMed ID: 18929550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
